Gravitate Health FHIR Implementation Guide (FHIR R4)
0.1.0 - CI Build
Gravitate Health FHIR Implementation Guide (FHIR R4)
0.1.0 - CI Build
Gravitate Health FHIR Implementation Guide (FHIR R4), published by . This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health-ips/ and changes regularly. See the Directory of published versions
<Bundle xmlns="http://hl7.org/fhir">
<id value="gravitate-helen"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/ips/StructureDefinition/Bundle-uv-ips"/>
</meta>
<identifier>
<system value="https://www.gravitatehealth.eu/sid/doc"/>
<value value="helen-ips-1"/>
</identifier>
<type value="document"/>
<timestamp value="2021-04-18T09:22:00+02:00"/>
<entry>
<fullUrl
value="https://myserver.org/Composition/5702fd1d-dd26-402e-a7c0-7629a5d9bba1"/>
<resource>
<Composition>
<id value="gravitate-helen"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Composition_gravitate-helen"> </a><p><b>Generated Narrative: Composition</b><a name="gravitate-helen"> </a><a name="hcgravitate-helen"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceComposition "gravitate-helen" </p></div><p><b>status</b>: final</p><p><b>type</b>: Patient summary Document <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://loinc.org/">LOINC</a>#60591-5)</span></p><p><b>date</b>: 2018-07-10 15:22:00+0200</p><p><b>author</b>: See on this page: Practitioner/45cd0bd4-f685-4117-a9f0-5c53fffb7266: Dr. Anna Karlsson</p><p><b>title</b>: Patient Summary (Helen Gravitate)</p><p><b>confidentiality</b>: N</p></div>
</text>
<status value="final"/>
<type>
<coding>
<system value="http://loinc.org"/>
<code value="60591-5"/>
<display value="Patient summary Document"/>
</coding>
</type>
<subject>
<reference value="Patient/be61951b-44fc-4853-8822-f9d398193c50"/>
<display value="Helen Gravitate"/>
</subject>
<date value="2018-07-10T15:22:00+02:00"/>
<author>
<reference
value="Practitioner/45cd0bd4-f685-4117-a9f0-5c53fffb7266"/>
<display value="Dr. Anna Karlsson"/>
</author>
<title value="Patient Summary (Helen Gravitate)"/>
<confidentiality value="N"/>
<section>
<title value="Allergies and Intolerances"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="48765-2"/>
<display value="Allergies and adverse reactions Document"/>
</coding>
</code>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><ul><li>Hay fever (pollen)</li></ul></div>
</text>
<entry>
<reference
value="AllergyIntolerance/cb6e84fa-4302-4569-ac1c-6b1b32507d16"/>
<display value="Lactose Intolerance"/>
</entry>
</section>
<section>
<title value="Problem List"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="11450-4"/>
<display value="Problem list Reported"/>
</coding>
</code>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><ul><li>Diabetes type 1</li></ul></div>
</text>
<entry>
<reference
value="Condition/de06df6b-0967-4b01-822b-7cfeea970aa7"/>
<display value="Diabetes type 1"/>
</entry>
</section>
<section>
<title value="Medication Summary"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="10160-0"/>
<display value="Hx of Medication use"/>
</coding>
</code>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><table><thead><tr><th>Brand Name</th><th>MAN</th><th>Active Substance</th><th>Common Name</th><th>ATC</th><th>Strength</th><th>Dose Form</th><th>RoA</th></tr></thead><tbody><tr><td>Humalog Mix50 Insulin KwikPen, 3ml pre-fill</td><td>EU/1/96/007/035</td><td>insulin lispro (GFX7QIS1II)</td><td>insulin lispro</td><td>A10AD04</td><td>100 U/ml</td><td>Suspension for injection</td><td>Subcutaneous use</td></tr><tr><td>Monuril 3 g granules for oral solution</td><td>PL31654/0006</td><td>FOSFOMYCIN (2N81MY12TE)</td><td>fosfomycin</td><td>J01XX01</td><td>3 g (as trometamol: 5.631g/sachet)</td><td>Granules for oral solution</td><td>Oral use</td></tr></tbody></table></div>
</text>
<entry>
<reference
value="MedicationStatement/18eb9898-dea7-4c5e-b097-e507e011747b"/>
<display value="Humalog Mix50 Insulin KwikPen, 3ml pre-fill"/>
</entry>
<entry>
<reference
value="MedicationStatement/c90b943a-3d8e-4f14-b56d-5c5c208b2065"/>
<display value="Monuril 3 g granules for oral solution"/>
</entry>
</section>
</Composition>
</resource>
</entry>
<entry>
<fullUrl
value="https://myserver.org/Patient/be61951b-44fc-4853-8822-f9d398193c50"/>
<resource>
<Patient>
<id value="be61951b-44fc-4853-8822-f9d398193c50"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml">Helen Gravitate, Female, 75 years old (1946-05-05)</div>
</text>
<extension
url="http://hl7.org/fhir/StructureDefinition/patient-citizenship">
<extension url="code">
<valueCodeableConcept>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="GB"/>
<display
value="United Kingdom of Great Britain and Northern Ireland"/>
</coding>
</valueCodeableConcept>
</extension>
</extension>
<identifier>
<system value="https://www.gravitatehealth.eu/sid/doc"/>
<value value="helen-1"/>
</identifier>
<active value="true"/>
<name>
<family value="Gravitate"/>
<given value="Helen"/>
</name>
<gender value="female"/>
<birthDate value="1946-05-05"/>
</Patient>
</resource>
</entry>
<entry>
<fullUrl
value="https://myserver.org/Practitioner/45cd0bd4-f685-4117-a9f0-5c53fffb7266"/>
<resource>
<Practitioner>
<id value="45cd0bd4-f685-4117-a9f0-5c53fffb7266"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml">Dr. Anne Karlsson</div>
</text>
<name>
<family value="Karlsson"/>
<given value="Anne"/>
<prefix value="Dr."/>
</name>
</Practitioner>
</resource>
</entry>
<entry>
<fullUrl
value="https://myserver.org/AllergyIntolerance/cb6e84fa-4302-4569-ac1c-6b1b32507d16"/>
<resource>
<AllergyIntolerance>
<id value="cb6e84fa-4302-4569-ac1c-6b1b32507d16"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml">Lactose Intolerance</div>
</text>
<clinicalStatus>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical"/>
<code value="active"/>
</coding>
</clinicalStatus>
<verificationStatus>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/allergyintolerance-verification"/>
<code value="confirmed"/>
</coding>
</verificationStatus>
<code>
<coding>
<system value="http://snomed.info/sct"/>
<code value="47703008"/>
<display value="Lactose"/>
</coding>
</code>
<patient>
<reference value="Patient/be61951b-44fc-4853-8822-f9d398193c50"/>
<display value="Helen Gravitate"/>
</patient>
</AllergyIntolerance>
</resource>
</entry>
<entry>
<fullUrl
value="https://myserver.org/Condition/de06df6b-0967-4b01-822b-7cfeea970aa7"/>
<resource>
<Condition>
<id value="de06df6b-0967-4b01-822b-7cfeea970aa7"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml">Diabetes mellitus type 1 (2015)</div>
</text>
<clinicalStatus>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/condition-clinical"/>
<code value="active"/>
</coding>
</clinicalStatus>
<code>
<coding>
<system value="http://snomed.info/sct"/>
<code value="46635009"/>
<display value="Diabetes mellitus type 1"/>
</coding>
<text value="Diabetes type 1"/>
</code>
<subject>
<reference value="Patient/be61951b-44fc-4853-8822-f9d398193c50"/>
<display value="Helen Gravitate"/>
</subject>
<onsetDateTime value="2015"/>
<asserter>
<reference
value="Practitioner/45cd0bd4-f685-4117-a9f0-5c53fffb7266"/>
<display value="Dr. Anna Karlsson"/>
</asserter>
</Condition>
</resource>
</entry>
<entry>
<fullUrl
value="https://myserver.org/MedicationStatement/18eb9898-dea7-4c5e-b097-e507e011747b"/>
<resource>
<MedicationStatement>
<id value="18eb9898-dea7-4c5e-b097-e507e011747b"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><table><thead><tr><th>Brand Name</th><th>MAN</th><th>Active Substance</th><th>Common Name</th><th>ATC</th><th>Strength</th><th>Dose Form</th><th>RoA</th></tr></thead><tbody><tr><td>Humalog Mix50 Insulin KwikPen, 3ml pre-fill</td><td>EU/1/96/007/035</td><td>insulin lispro (GFX7QIS1II)</td><td>insulin lispro</td><td>A10AD04</td><td>100 U/ml</td><td>Suspension for injection</td><td>Subcutaneous use</td></tr></tbody></table></div>
</text>
<status value="active"/>
<medicationReference>
<reference value="Medication/9d7be868-8264-4d94-ad04-ef04ecc92e50"/>
<display value="Humalog Mix50 Insulin KwikPen, 3ml pre-fill"/>
</medicationReference>
<subject>
<reference value="Patient/be61951b-44fc-4853-8822-f9d398193c50"/>
<display value="Helen Gravitate"/>
</subject>
<dosage>
<route>
<coding>
<system value="http://standardterms.edqm.eu"/>
<code value="20066000"/>
<display value="Subcutaneous use"/>
</coding>
</route>
</dosage>
</MedicationStatement>
</resource>
</entry>
<entry>
<fullUrl
value="https://myserver.org/MedicationStatement/c90b943a-3d8e-4f14-b56d-5c5c208b2065"/>
<resource>
<MedicationStatement>
<id value="c90b943a-3d8e-4f14-b56d-5c5c208b2065"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><table><thead><tr><th>Brand Name</th><th>MAN</th><th>Active Substance</th><th>Common Name</th><th>ATC</th><th>Strength</th><th>Dose Form</th><th>RoA</th></tr></thead><tbody><tr><td>Monuril 3 g granules for oral solution</td><td>PL31654/0006</td><td>FOSFOMYCIN (2N81MY12TE)</td><td>fosfomycin</td><td>J01XX01</td><td>3 g (as trometamol: 5.631g/sachet)</td><td>Granules for oral solution</td><td>Oral use</td></tr></tbody></table></div>
</text>
<basedOn>
<reference
value="MedicationRequest/c872135e-f219-4f32-8fd6-7099009abf42"/>
</basedOn>
<status value="active"/>
<medicationReference>
<reference value="Medication/fdb5c97f-0a46-41ba-bc34-2efd2ef2f7e3"/>
<display value="Monuril 3g granules for oral solution"/>
</medicationReference>
<subject>
<reference value="Patient/be61951b-44fc-4853-8822-f9d398193c50"/>
<display value="Helen Gravitate"/>
</subject>
<dosage>
<route>
<coding>
<system value="http://standardterms.edqm.eu"/>
<code value="20053000"/>
<display value="Oral use"/>
</coding>
</route>
</dosage>
</MedicationStatement>
</resource>
</entry>
<entry>
<fullUrl
value="https://myserver.org/MedicationRequest/c872135e-f219-4f32-8fd6-7099009abf42"/>
<resource>
<MedicationRequest>
<id value="c872135e-f219-4f32-8fd6-7099009abf42"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="MedicationRequest_c872135e-f219-4f32-8fd6-7099009abf42"> </a><p><b>Generated Narrative: MedicationRequest</b><a name="c872135e-f219-4f32-8fd6-7099009abf42"> </a><a name="hcc872135e-f219-4f32-8fd6-7099009abf42"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceMedicationRequest "c872135e-f219-4f32-8fd6-7099009abf42" </p></div><p><b>status</b>: active</p><p><b>intent</b>: order</p><p><b>medication</b>: See on this page: Medication/fdb5c97f-0a46-41ba-bc34-2efd2ef2f7e3: Monuril</p><p><b>subject</b>: See on this page: Patient/be61951b-44fc-4853-8822-f9d398193c50</p></div>
</text>
<status value="active"/>
<intent value="order"/>
<medicationReference>
<reference value="Medication/fdb5c97f-0a46-41ba-bc34-2efd2ef2f7e3"/>
<display value="Monuril"/>
</medicationReference>
<subject>
<reference value="Patient/be61951b-44fc-4853-8822-f9d398193c50"/>
</subject>
</MedicationRequest>
</resource>
</entry>
<entry>
<fullUrl
value="https://myserver.org/Medication/9d7be868-8264-4d94-ad04-ef04ecc92e50"/>
<resource>
<Medication>
<id value="9d7be868-8264-4d94-ad04-ef04ecc92e50"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Medication_9d7be868-8264-4d94-ad04-ef04ecc92e50"> </a><p><b>Generated Narrative: Medication</b><a name="9d7be868-8264-4d94-ad04-ef04ecc92e50"> </a><a name="hc9d7be868-8264-4d94-ad04-ef04ecc92e50"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceMedication "9d7be868-8264-4d94-ad04-ef04ecc92e50" </p></div><p><b>code</b>: Humalog Mix50 KwikPen 100 U/ml 5 pre-filled pen <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (pmswi#EU/1/96/007/035; phpid#0xF79CABF272B6A7EEF104DDDA44E82717 "Insulin Lispro 100 U/ml 5 pre-filled pen"; <a href="https://browser.ihtsdotools.org/">SNOWMED CT</a>#388454007 "Product containing insulin lispro (medicinal product)"; <a href="http://terminology.hl7.org/5.5.0/CodeSystem-v3-WC.html">WHO ATC</a>#A10AD04 "insulin lispro")</span></p><p><b>form</b>: Suspension for injection <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (standardterms.edqm.eu#11202000)</span></p><h3>Ingredients</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td><td><b>Strength</b></td></tr><tr><td style="display: none">*</td><td>insulin lispro <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.5.0/CodeSystem-UNII.html">Unique Ingredient Identifier (UNII)</a>#GFX7QIS1II)</span></td><td>100 units<span style="background: LightGoldenRodYellow"> (Details: UCUM code U = 'U')</span>/1 ml<span style="background: LightGoldenRodYellow"> (Details: UCUM code ml = 'ml')</span></td></tr></table></div>
</text>
<code>
<coding>
<system value="https://spor.ema.europa.eu/pmswi"/>
<code value="EU/1/96/007/035"/>
<display value="Humalog Mix50 KwikPen 100 U/ml 5 pre-filled pen"/>
</coding>
<coding>
<system value="https://www.who-umc.org/phpid"/>
<code value="0xF79CABF272B6A7EEF104DDDA44E82717"/>
<display value="Insulin Lispro 100 U/ml 5 pre-filled pen"/>
</coding>
<coding>
<system value="http://snomed.info/sct"/>
<code value="388454007"/>
<display
value="Product containing insulin lispro (medicinal product)"/>
</coding>
<coding>
<system value="http://www.whocc.no/atc"/>
<code value="A10AD04"/>
<display value="insulin lispro"/>
</coding>
</code>
<form>
<coding>
<system value="http://standardterms.edqm.eu"/>
<code value="11202000"/>
<display value="Suspension for injection"/>
</coding>
</form>
<ingredient>
<itemCodeableConcept>
<coding>
<system value="http://fdasis.nlm.nih.gov"/>
<code value="GFX7QIS1II"/>
<display value="insulin lispro"/>
</coding>
<text value="insulin lispro"/>
</itemCodeableConcept>
<strength>
<numerator>
<value value="100"/>
<unit value="units"/>
<system value="http://unitsofmeasure.org"/>
<code value="U"/>
</numerator>
<denominator>
<value value="1"/>
<unit value="ml"/>
<system value="http://unitsofmeasure.org"/>
<code value="ml"/>
</denominator>
</strength>
</ingredient>
</Medication>
</resource>
</entry>
<entry>
<fullUrl
value="https://myserver.org/Medication/fdb5c97f-0a46-41ba-bc34-2efd2ef2f7e3"/>
<resource>
<Medication>
<id value="fdb5c97f-0a46-41ba-bc34-2efd2ef2f7e3"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Medication_fdb5c97f-0a46-41ba-bc34-2efd2ef2f7e3"> </a><p><b>Generated Narrative: Medication</b><a name="fdb5c97f-0a46-41ba-bc34-2efd2ef2f7e3"> </a><a name="hcfdb5c97f-0a46-41ba-bc34-2efd2ef2f7e3"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceMedication "fdb5c97f-0a46-41ba-bc34-2efd2ef2f7e3" </p></div><p><b>code</b>: Monuril <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (pmswi#PL31654/0087; phpid#0xE857DA811B4A6F3BD57810C45D2EA1RF "Fosfomycin, 3g, Granules for oral solution"; <a href="http://terminology.hl7.org/5.5.0/CodeSystem-v3-WC.html">WHO ATC</a>#J01XX01 "fosfomycin")</span></p><p><b>form</b>: Granules for oral solution <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (standardterms.edqm.eu#10112000)</span></p><h3>Ingredients</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td><td><b>Strength</b></td></tr><tr><td style="display: none">*</td><td>FOSFOMYCIN TROMETAMOL <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.5.0/CodeSystem-UNII.html">Unique Ingredient Identifier (UNII)</a>#7FXW6U30GY "FOSFOMYCIN TROMETHAMINE")</span></td><td>5.631 g<span style="background: LightGoldenRodYellow"> (Details: UCUM code g = 'g')</span>/1 Sachet<span style="background: LightGoldenRodYellow"> (Details: UCUM code {sachet} = '{sachet}')</span></td></tr></table></div>
</text>
<code>
<coding>
<system value="https://spor.ema.europa.eu/pmswi"/>
<code value="PL31654/0087"/>
<display value="Monuril"/>
</coding>
<coding>
<system value="https://www.who-umc.org/phpid"/>
<code value="0xE857DA811B4A6F3BD57810C45D2EA1RF"/>
<display value="Fosfomycin, 3g, Granules for oral solution"/>
</coding>
<coding>
<system value="http://www.whocc.no/atc"/>
<code value="J01XX01"/>
<display value="fosfomycin"/>
</coding>
</code>
<form>
<coding>
<system value="http://standardterms.edqm.eu"/>
<code value="10112000"/>
<display value="Granules for oral solution"/>
</coding>
</form>
<ingredient>
<itemCodeableConcept>
<coding>
<system value="http://fdasis.nlm.nih.gov"/>
<code value="7FXW6U30GY"/>
<display value="FOSFOMYCIN TROMETHAMINE"/>
</coding>
<text value="FOSFOMYCIN TROMETAMOL"/>
</itemCodeableConcept>
<strength>
<numerator>
<value value="5.631"/>
<unit value="g"/>
<system value="http://unitsofmeasure.org"/>
<code value="g"/>
</numerator>
<denominator>
<value value="1"/>
<unit value="Sachet"/>
<system value="http://unitsofmeasure.org"/>
<code value="{sachet}"/>
</denominator>
</strength>
</ingredient>
</Medication>
</resource>
</entry>
</Bundle>
IG © 2021+ . Package hl7.eu.fhir.gh-ips#0.1.0 based on FHIR 4.0.1. Generated 2024-05-14
Links: Table of Contents |
QA Report
The Gravitate Health project has received funding from the IMI 2 Joint Undertaking under grant agreement No 945334.
This joint undertaking receives support from the EU H2020 research and innovation programme and EFPIA.
